IA

Integra Lifesciences Holdings CorpNASDAQ IART Stock Report

Last reporting period 30 Jun, 2024

Updated 01 Nov, 2024

Last price

Market cap $B

1.387

Small

Exchange

XNAS - Nasdaq

View Section: Eyestock Rating

Integra Lifesciences Fair Value

IA

The fair market value of IART stock is 10.03 USD. Relative to the market price of 19.28 USD Integra Lifesciences is overvalued by 48%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Overvalued 48%
10.03 USD
IART Fair Value
19.28 USD
Market price of IART

Integra Lifesciences Valuation

Current IART share ticker price is 19.28 USD.

The fair value level of 10.03 USD can be considered as an effective entry point for long-term investors to start investing in IART stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 48% higher its fair value

Min value

Current price is 60% higher its minimum value

Max value

Current price is 39% lower its maximum value

02.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

IART stock is overvalued

It means the current price may concern as a Risky Entry Point

Integra Lifesciences Holdings Corp Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

91.36

2

Median P/E over 5 years

34.11

3

Minimum P/E over 5 years

26.35

4

Earning per share (last 12 months)

0.29 USD

Maximum value

1

x

4

=

26.85 USD

Fair value

2

x

4

=

10.03 USD

Minimum value

3

x

4

=

7.75 USD

Integra Lifesciences Holdings Corp price metrics

-19.86

Annual return (geometric mean)

37.64

Risk (standard deviation) of returns

β

1.09

Beta (volatility compared to market)

It means that IART stock is more volatile than the broader market

Discover Undervalued Companies


View Section: Profitability